-
D648708-10mgDofequidar fumarate(MS-209 fumarate), an orally active quinoline compound, has been reported to overcome MDR by inhibiting ABCB1/P-gp, ABCC1/MDR-associated protein 1, or both.IC50 value:Target: P-gpin vitro: MS-209 at 3 microM effectively overcame
-
D648708-50mgDofequidar fumarate(MS-209 fumarate), an orally active quinoline compound, has been reported to overcome MDR by inhibiting ABCB1/P-gp, ABCC1/MDR-associated protein 1, or both.IC50 value:Target: P-gpin vitro: MS-209 at 3 microM effectively overcame
-
D648708-5mgDofequidar fumarate(MS-209 fumarate), an orally active quinoline compound, has been reported to overcome MDR by inhibiting ABCB1/P-gp, ABCC1/MDR-associated protein 1, or both.IC50 value:Target: P-gpin vitro: MS-209 at 3 microM effectively overcame
-
D655535-1mlDofequidar fumarate(MS-209 fumarate), an orally active quinoline compound, has been reported to overcome MDR by inhibiting ABCB1/P-gp, ABCC1/MDR-associated protein 1, or both.IC50 value:Target: P-gpin vitro: MS-209 at 3 microM effectively overcame
-
E649881-100mgEncequidar mesylate (HM30181 mesylate HM30181A mesylate) is a competitive and potent P-glycoprotein inhibitor.In VitroTreatment of 0.1 or 1 nM Encequidar (HM30181) lead to 20 and 42% inhibition of survival at the 100 nM and 1000 nM NSC 125973
-
E649881-10mgEncequidar mesylate (HM30181 mesylate HM30181A mesylate) is a competitive and potent P-glycoprotein inhibitor.In VitroTreatment of 0.1 or 1 nM Encequidar (HM30181) lead to 20 and 42% inhibition of survival at the 100 nM and 1000 nM NSC 125973
-
E649881-50mgEncequidar mesylate (HM30181 mesylate HM30181A mesylate) is a competitive and potent P-glycoprotein inhibitor.In VitroTreatment of 0.1 or 1 nM Encequidar (HM30181) lead to 20 and 42% inhibition of survival at the 100 nM and 1000 nM NSC 125973
-
E649881-5mgEncequidar mesylate (HM30181 mesylate HM30181A mesylate) is a competitive and potent P-glycoprotein inhibitor.In VitroTreatment of 0.1 or 1 nM Encequidar (HM30181) lead to 20 and 42% inhibition of survival at the 100 nM and 1000 nM NSC 125973
-
E656039-1mlEncequidar mesylate (HM30181 mesylate HM30181A mesylate) is a competitive and potent P-glycoprotein inhibitor.In VitroTreatment of 0.1 or 1 nM Encequidar (HM30181) lead to 20 and 42% inhibition of survival at the 100 nM and 1000 nM NSC 125973
-
-
-